Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream

Drug Delivery

Volumn 17, Issue 8, 2010, Pages 617-623

  Cui, Fuying ^a,b   Li, Guodong ^b   Huang, Jinjiang ^b   Zhang, Jien ^b   Lu, Min ^b   Lu, Wanying ^b   Huang, Qingshan ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Hi Tech United Bio technological Research and Development Co Ltd   (China)

Author keywords

Anti staphylococcus aureus; Lysostaphin; Mucoadhesion; Nasal colonization.; The CCL cream

Indexed keywords

CHITOSAN; GRAPHITE; LYSOSTAPHIN; OIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GROWTH INHIBITION; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CROSS INFECTION; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; LYSOSTAPHIN; MATERIALS TESTING; MICE; MICE, NUDE; MICROBIAL SENSITIVITY TESTS; MUCOCILIARY CLEARANCE; NASAL MUCOSA; OINTMENT BASES; PETROLATUM; RATS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77957745051     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.509360     Document Type: Review

References (17)

1. Amidi M., Mastrobattista E., Jiskoot W., Hennink W.E. (2010). Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 62: 59-82.
2. Bhakta, M., Arora, S., Bal, M. (2003). Intraspecies transfer of a chloramphenicol-resistance plasmid of staphylococcal origin. Indian J Med Res. 117:146-51.
3. Bloom, B.S., Fendrick, A.M., Chernew, M.E., Patel, P. (1996). Clinical and economic efects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am J Kidney Dis. 27:687-94.
4. Bunjes, H., Unruh, T. (2007). Characterization of lipid nanoparticles by diferential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 59:379-402.
5. Dajcs, J.J., Hume, E.B., Moreau, J.M., Caballero, A.R., Cannon, B.M., O'Callaghan, R.J. (2000). Lysostaphin treatment of methicillinresistant staphylococcus aureus keratitis in the rabbit (1). Am J Ophthalmol. 130:544.
6. Jia, X.Y., Chen, X., Xu, Y.L., Han, X.Y., Xu, Z.R. (2009). Tracing transport of chitosan nanoparticles and molecules in Caco-2 cells by fuorescent labeling. Carbohydr Polym. 78:323-9.
7. Kokai-Kun, J.F., Walsh, S.M., Chanturiya, T., Mond, J.J. (2003). Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother. 47:1589-97.
8. Lee, Y.H., Mei, F., Bai, M.Y, Zhao, S.L., Chen, D.R. (2010). Release profle characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray. J Contr Rel. 145:58-65.
9. Lim, S.T., Martin, G.P., Berry, D.J., Brown, M.B. (2000). Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Contr Rel. 66:281-92.
10. Mody, L., Kaufman, C.A., McNeil, S.A., Galecki, A.T., Bradley, S.F. (2003). Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 37:1467-74.
11. Peacock, S.J., de Silva, I., Lowy, F.D. (2001). What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 9:605-10.
12. Perl, T.M., Cullen, J.J., Wenzel, R.P., Zimmerman, M.B., Pfaller, M.A., Sheppard, D., Twombley, J., French, P.P., Herwaldt, L.A. (2002). Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 346:1871-7.
13. Schindler, C.A., Schuhardt, V.T. (1964). Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA. 51:414-21.
14. Trautmann, M., Stecher, J., Hemmer, W., Luz, K., Panknin, H.T. (2008). Intranasal mupirocin prophylaxis in elective surgery. Chemotherapy. 54:9-16.
15. Valenta, C., Wanka, M., Heidlas, J. (2000). Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J Contr Rel. 63:165-73.
16. Walsh, S., Kokai-Kun, J., Shah, A., Mond, J. (2004). Extended nasal residence time of lysostaphin and an anti-Staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers. Pharm Res. 21:1770-5.
17. Zhou, R., Chen, S., Recsei, P. (1988). A dye release assay for determination of lysostaphin activity. Anal Biochem. 171:141-4.